Literature DB >> 6858872

Coronary dilatory capacity in idiopathic dilated cardiomyopathy: analysis of 16 patients.

D Opherk, F Schwarz, G Mall, J Manthey, D Baller, W Kübler.   

Abstract

Hemodynamic function and overall coronary blood flow (argon technique) were measured in 16 patients with idiopathic dilated cardiomyopathy (IDC) and in 12 patients without detectable heart disease (control subjects) referred for precordial pain. In patients with IDC, coronary blood flow was normal at rest (78 +/- 17 ml/100 g-min versus 78 +/- 9 in control subjects). During maximal inducible coronary vasodilation (dipyridamole, 0.5 mg/kg), coronary blood flow was significantly reduced (142 +/- 38 ml/100 g.min versus 301 +/- 64 in control subjects; p less than 0.001). Consequently, obtainable minimal coronary resistance was increased in IDC (0.54 +/- 0.20 mm Hg/ml/100 g.min versus 0.23 +/- 0.04 in control subjects; p less than 0.001). In patients with IDC, left ventricular (LV) end-diastolic pressure was significantly increased (19 +/- 11 mm Hg versus 6 +/- 3 in control subjects; p less than 0.005), and the LV ejection fraction was diminished (36 +/- 11% versus 72 +/- 3% in control subjects; p less than 0.001). In patients with IDC, LV end-diastolic pressure correlated significantly with the obtained minimal coronary resistance after application of dipyridamole (r = 0.85; p less than 0.001). LV catheter biopsy specimens revealed no alterations in myocardial microvasculature. Thus, coronary dilatory capacity is impaired in patients with IDC, due partially to an increase in extravascular component of coronary resistance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6858872     DOI: 10.1016/0002-9149(83)90205-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Myocardial blood volume reserve by intravenous contrast echocardiography predicts improvement in left ventricular function in patients with nonischemic dilated cardiomyopathy.

Authors:  Yoko Miyata-Fukuoka; Hiroya Kawai; Osamu Iseki; Yoshio Yamanaka; Yoshiaki Ueda; Mitsuhiro Yokoyama; Ken-Ichi Hirata
Journal:  J Echocardiogr       Date:  2016-07-09

2.  Perfusion and mechanical analysis with technetium-99m 2-methoxy-isobutyl-isonitrile in a case of dilated cardiomyopathy.

Authors:  T Takeda; H Toyama; N Ishikawa; T Masuoka; R Ajisaka; K Iida; M Satoh; W Jin; T Saitou; T Yamanouchi
Journal:  Ann Nucl Med       Date:  1992-05       Impact factor: 2.668

Review 3.  Validation of noninvasive studies for detecting coronary artery disease: beauty versus blood flow.

Authors:  R F Wilson
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

Review 4.  Syndrome X.

Authors:  A H Henderson
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

5.  Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.

Authors:  R D Cohn; M Durbeej; S A Moore; R Coral-Vazquez; S Prouty; K P Campbell
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 6.  Quantitative myocardial perfusion imaging by cardiovascular magnetic resonance and positron emission tomography.

Authors:  K Bratis; I Mahmoud; A Chiribiri; E Nagel
Journal:  J Nucl Cardiol       Date:  2013-07-19       Impact factor: 5.952

7.  Increased production of nitric oxide in coronary arteries during congestive heart failure.

Authors:  B O'Murchu; V M Miller; M A Perrella; J C Burnett
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.

Authors:  Michael Bietenbeck; Anca Florian; Zornitsa Shomanova; Claudia Meier; Ali Yilmaz
Journal:  Clin Res Cardiol       Date:  2018-05-17       Impact factor: 5.460

Review 9.  Recent advances in cellular effects of fluoride: an update on its signalling pathway and targeted therapeutic approaches.

Authors:  Apoorva H Nagendra; Bipasha Bose; Sudheer Shenoy P
Journal:  Mol Biol Rep       Date:  2021-07-12       Impact factor: 2.316

10.  No Evidence of Myocardial Oxygen Deprivation in Nonischemic Heart Failure.

Authors:  Sairia Dass; Cameron J Holloway; Lowri E Cochlin; Oliver J Rider; Masliza Mahmod; Matthew Robson; Emily Sever; Kieran Clarke; Hugh Watkins; Houman Ashrafian; Theodoros D Karamitsos; Stefan Neubauer
Journal:  Circ Heart Fail       Date:  2015-09-02       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.